Atlas Trials

Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China

Clinical trial NCT04507269 · COMPLETED

Trial details

NCT number
NCT04507269
Sponsor
Brii Biosciences Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2020-08-18
Primary completion
2021-09-30
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.